Overall (n = 1986) | HR+/HER2- (n = 871) | HR+/HER2+ (n = 150) | HR−/HER2+ (n = 275) | HR−/HER2- (n = 443) | P | |
---|---|---|---|---|---|---|
Age,y,No. (%) | 0.736 | |||||
< 50 | 614(30.9) | 264 (30.3) | 132 (33.2) | 84 (30.5) | 134 (30.2) | |
≥ 50 | 1372 (69.1) | 607 (69.7) | 265 (66.8) | 191 (69.5) | 309 (69.8) | |
Race,No. (%) | < 0.001 | |||||
Black | 358 (18.0) | 133 (15.3) | 62 (15.6) | 44 (16.0) | 119 (26.9) | |
White | 1432 (72.1) | 639 (73.4) | 298 (75.1) | 208 (75.6) | 287 (64.8) | |
Other | 196 (9.9) | 99 (11.4) | 37 (9.3) | 23 (8.4) | 37 (8.4) | |
Tumor stage, No. (%) | 0.218 | |||||
IIIB | 1622 (81.7) | 728 (83.6) | 316 (79.6) | 225 (81.8) | 353 (79.7) | |
IIIC | 364 (18.3) | 143 (16.4) | 81 (20.4) | 50 (18.2) | 90 (20.3) | |
Grade,No. (%) | < 0.001 | |||||
1/2 | 659 (33.2) | 299 (45.8) | 150 (37.8) | 56 (20.4) | 54 (12.2) | |
3 | 1220 (61.4) | 428 (49.1) | 223 (56.2) | 201 (73.1) | 368 (83.1) | |
Unknown | 107 (5.4) | 44 (5.1) | 24 (6.0) | 18 (6.5) | 21 (4.7) | |
Surgery,No. (%) | 0.104 | |||||
Partial mastectomy | 190 (9.6) | 93 (10.7) | 33 (8.3) | 17 (6.2) | 47 (10.6) | |
Mastectomy | 1796 (90.4) | 778 (89.3) | 364 (91.7) | 258 (93.8) | 396 (89.4) | |
Breast cancer type, No. (%) | < 0.001 | |||||
IBC | 737 (37.1) | 259 (29.7) | 164 (41.3) | 136 (49.5) | 178 (40.2) | |
T4-non-IBC | 1249 (62.9) | 612 (70.3) | 233 (58.7) | 139 (50.5) | 265 (59.8) |